PYXS vs ZBH · rev $2.8M vs P/E 23, rev $4.26B
Pyxis Oncology Inc (PYXS) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
PYXS currently screens at market cap $109.6M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the PYXS and ZBH stock pages for the full models.
Not investment advice.